Abiopharma

🔍 Clevenger Marvin Bradford (Executive)

Company: Rocket Lab Corp (RKLB)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Sold 13,924 shares of Common Stock at $69.5345 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 460,051.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 450 shares of Common Stock at $70.2023 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 459,601.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 677 shares of Common Stock at $71.17 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 458,924.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the sale of shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
• F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $69.0000 to $69.9900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.